• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ayurveda GCP Guidelines: Need for freedom from RCT ascendancy in favor of whole system approach.

作者信息

Patwardhan Bhushan

机构信息

Editor-in-Chief, Institute of Ayurveda and Integrative Medicine, Bangalore, India. E-mail:

出版信息

J Ayurveda Integr Med. 2011 Jan;2(1):1-4. doi: 10.4103/0975-9476.78175.

DOI:10.4103/0975-9476.78175
PMID:21731379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3121247/
Abstract
摘要

相似文献

1
Ayurveda GCP Guidelines: Need for freedom from RCT ascendancy in favor of whole system approach.阿育吠陀药物临床试验质量管理规范指南：摆脱随机对照试验主导地位转而支持整体系统方法的必要性。
J Ayurveda Integr Med. 2011 Jan;2(1):1-4. doi: 10.4103/0975-9476.78175.
2
Exploring issues in the development of Ayurvedic research methodology.探索阿育吠陀研究方法发展中的问题。
J Ayurveda Integr Med. 2010 Apr;1(2):91-5. doi: 10.4103/0975-9476.65067.
3
RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities.阿育吠陀医学中的随机对照试验及其他临床试验设计：挑战与机遇综述
J Ayurveda Integr Med. 2021 Jul-Sep;12(3):556-561. doi: 10.1016/j.jaim.2021.06.012. Epub 2021 Aug 3.
4
Ayurveda and botanical drugs for epilepsy: Current evidence and future prospects.阿育吠陀医学与治疗癫痫的植物药：当前证据与未来前景。
Epilepsy Behav. 2015 Nov;52(Pt B):290-6. doi: 10.1016/j.yebeh.2015.05.039. Epub 2015 Jul 2.
5
Dosha phenotype specific Ayurveda intervention ameliorates asthma symptoms through cytokine modulations: Results of whole system clinical trial.基于体质表型的阿育吠陀干预通过细胞因子调节改善哮喘症状：全系统临床试验结果。
J Ethnopharmacol. 2017 Feb 2;197:110-117. doi: 10.1016/j.jep.2016.07.071. Epub 2016 Jul 26.
6
Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies Program.在临床试验实施中推广良好临床实践：退伍军人事务部协作研究项目的经验
Control Clin Trials. 2003 Oct;24(5):570-84. doi: 10.1016/s0197-2456(03)00074-6.
7
WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator.世界卫生组织药品临床试验良好临床实践（GCP）指南：研究者的职责
Ann Med. 1994 Apr;26(2):89-94. doi: 10.3109/07853899409147334.
8
[Good clinical practice (GCP)].[良好临床规范（GCP）]
Theriaca. 1998 Sep;31:7-53.
9
An 'Ayurveda-Biology' platform for integrative diabetes management.基于阿育吠陀-生物学的糖尿病综合管理平台。
J Ethnopharmacol. 2021 Mar 25;268:113575. doi: 10.1016/j.jep.2020.113575. Epub 2020 Nov 9.
10
[ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].[国际人用药品注册技术协调会 - 药物临床试验质量管理规范指南：临床试验的质量保证。现状与展望]
Ugeskr Laeger. 2003 Apr 14;165(16):1659-62.

引用本文的文献

1
Ayurveda and in silico Approach: A Challenging Proficient Confluence for Better Development of Effective Traditional Medicine Spotlighting Network Pharmacology.阿育吠陀和计算方法：有效传统医学更好发展的富有挑战性的精通融合点，突显网络药理学。
Chin J Integr Med. 2023 May;29(5):470-480. doi: 10.1007/s11655-022-3584-x. Epub 2022 Sep 12.
2
RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities.阿育吠陀医学中的随机对照试验及其他临床试验设计：挑战与机遇综述
J Ayurveda Integr Med. 2021 Jul-Sep;12(3):556-561. doi: 10.1016/j.jaim.2021.06.012. Epub 2021 Aug 3.
3
Effectiveness of Ayurveda treatment in Urdhwaga Amlapitta: A clinical evaluation.阿育吠陀疗法治疗上逆性胃酸过多症的疗效：一项临床评估。
J Ayurveda Integr Med. 2021 Jan-Mar;12(1):87-92. doi: 10.1016/j.jaim.2020.12.004. Epub 2021 Feb 3.
4
Whole Medical Systems versus the System of Conventional Biomedicine: A Critical, Narrative Review of Similarities, Differences, and Factors That Promote the Integration Process.整体医学体系与传统生物医学体系：对相似性、差异及促进整合过程的因素的批判性叙述性综述
Evid Based Complement Alternat Med. 2017;2017:4904930. doi: 10.1155/2017/4904930. Epub 2017 Jul 13.
5
Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines?慢性肾病患者的低蛋白饮食：主流医学与补充替代医学之间的桥梁？
BMC Nephrol. 2016 Jul 8;17(1):76. doi: 10.1186/s12882-016-0275-x.
6
Ayurvedic research, wellness and consumer rights.阿育吠陀研究、健康与消费者权益。
J Ayurveda Integr Med. 2016 Mar;7(1):6-10. doi: 10.1016/j.jaim.2016.05.002. Epub 2016 May 25.
7
Ayurpharmacoepidemiology en Route to Safeguarding Safety and Efficacy of Ayurvedic Drugs in Global Outlook.阿育吠陀药物流行病学：在全球视野下保障阿育吠陀药物安全性与有效性的道路上
J Evid Based Complementary Altern Med. 2017 Apr;22(2):294-298. doi: 10.1177/2156587215624032. Epub 2016 Jun 22.
8
Integrative approach to health: Challenges and opportunities.健康的综合方法：挑战与机遇。
J Ayurveda Integr Med. 2015 Jul-Sep;6(3):215-9.
9
Meeting report: ayurveda group deliberations at 22(nd) annual cochrane colloquium 2014.会议报告：2014年第22届Cochrane年会阿育吠陀小组讨论
J Ayurveda Integr Med. 2015 Jan-Mar;6(1):68-70. doi: 10.4103/0975-9476.154249.
10
Modulation of Cardiac Autonomic Dysfunction in Ischemic Stroke following Ayurveda (Indian System of Medicine) Treatment.基于印度医学（阿育吠陀）治疗缺血性脑卒中的心脏自主神经功能障碍的调节。
Evid Based Complement Alternat Med. 2014;2014:634695. doi: 10.1155/2014/634695. Epub 2014 May 26.

本文引用的文献

1
Workshop on a CONSORT statement for Ayuveda.阿育吠陀随机对照试验报告规范研讨会
J Ayurveda Integr Med. 2010 Apr;1(2):158-9.
2
Traditional medicine and genomics.传统医学与基因组学。
J Ayurveda Integr Med. 2010 Jan;1(1):26-32. doi: 10.4103/0975-9476.59824.
3
Conceptual framework for new models of integrative medicine.整合医学新模式的概念框架。
J Ayurveda Integr Med. 2010 Jan;1(1):3-5. doi: 10.4103/0975-9476.59817.
4
Pharmacovigilance: Boon for the safety and efficacy of Ayuvedic formulations.药物警戒：阿育吠陀制剂安全性和有效性的福音。
J Ayurveda Integr Med. 2010 Oct;1(4):251-6. doi: 10.4103/0975-9476.74427.
5
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up.草药-矿物阿育吠陀疗法治疗一名二次复发的高危急性早幼粒细胞白血病患者：12年随访
J Ayurveda Integr Med. 2010 Jul;1(3):215-8. doi: 10.4103/0975-9476.72618.
6
Ayurveda-modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis.阿育吠陀医学与现代医学的界面：对治疗骨关节炎和类风湿关节炎的阿育吠陀药物研究的批判性评估。
J Ayurveda Integr Med. 2010 Jul;1(3):190-8. doi: 10.4103/0975-9476.72620.
7
Equipoise and the dilemma of randomized clinical trials.equipoise与随机临床试验的困境
N Engl J Med. 2011 Feb 3;364(5):476-80. doi: 10.1056/NEJMsb1011301.
8
Efficacy and safety of Ayurvedic medicines: Recommending equivalence trial design and proposing safety index.阿育吠陀药物的疗效与安全性：推荐等效性试验设计并提出安全指数。
Int J Ayurveda Res. 2010 Jul;1(3):175-80. doi: 10.4103/0974-7788.72491.
9
A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project.一项针对症状性膝骨关节炎的标准化阿育吠陀配方的随机对照探索性评估：印度政府 NMITLI 项目。
Evid Based Complement Alternat Med. 2011;2011:724291. doi: 10.1155/2011/724291. Epub 2010 Oct 11.
10
EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda.通过对印度阿育吠陀中定义的极端体质类型的遗传分析揭示 EGLN1 参与高空适应。
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18961-6. doi: 10.1073/pnas.1006108107. Epub 2010 Oct 18.